Not applicableStudy completedNCT01659814What this trial is testingDopamine Neurotransmission in Major DepressionWho this might be right forMajor Depressive DisorderAnhedonia Mclean Hospital 71
Not applicableWithdrawnNCT04032015What this trial is testingRTMS Study in Depression to Evaluate the Relationship Between Brain Plasticity and Clinical OutcomeWho this might be right forMajor Depressive Disorder Stanford University
Not applicableLooking for participantsNCT06183359What this trial is testingSelf-Identification ProgramWho this might be right forMajor Depressive DisorderThird Wave Cognitive Behavioral Therapy University Hospital, Montpellier 86
Testing effectiveness (Phase 2)Study completedNCT04088448What this trial is testingThe Antidiabetic Metformin as a Novel Adjunct to Antidepressants in Major Depressive Disorder PatientsWho this might be right forMajor Depressive Disorder Sadat City University 80
Not applicableUnknownNCT01851915What this trial is testingCognitive Behavioral Therapy and Interpersonal Psychotherapy as Treatment for Major Depressive DisorderWho this might be right forShort Term Therapy for Outpatients Diagnosed With Major Depressive Disorder Linkoeping University 96
Not applicableStudy completedNCT01692574What this trial is testingTreatment for Depressed, Obese Individuals at Risk for Cardiovascular Disease (CVD)Who this might be right forObesityMajor Depressive DisorderDysthymic Disorder+1 more University of Pennsylvania 76
Not applicableStudy completedNCT02309060What this trial is testingStorytelling Video Intervention for Depressed Primary Care Patients - Open TrialWho this might be right forMajor Depressive Disorder Butler Hospital 11
Testing effectiveness (Phase 2)Ended earlyNCT00880048What this trial is testingA Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive DisorderWho this might be right forDepressive Disorder GlaxoSmithKline 343
Not applicableActive Not RecruitingNCT07453420What this trial is testingProfiling Vulnerability and Resilience for Mental Illness Following Viral Infections: Translating Epidemiology to Deep-phenotyping.Who this might be right forAnxietyDepression - Major Depressive DisorderBipolar+1 more Shalvata Mental Health Center 100,000
Post-approval studies (Phase 4)Study completedNCT02191124What this trial is testingThe Measurement-based Care in Patients With Depressive Disorder: A Randomized Controlled TrialWho this might be right forMajor Depressive Disorder Capital Medical University 164
Testing effectiveness (Phase 2)UnknownNCT02395263What this trial is testingComparison of Yuxintine With Placebo in Treatment of MDDWho this might be right forMajor Depressive Disorder (MDD) Shanghai Mental Health Center 160
Not applicableStudy completedNCT04638231What this trial is testingSupportive Text Messaging Versus Supportive E-mail Messaging for Patients With Major Depressive DisorderWho this might be right forMajor Depressive Disorder University of Alberta 66
Not applicableNot Yet RecruitingNCT06532604What this trial is testingStudy of Electrophysiological Markers of Antidepressants in Major Depressive DisorderWho this might be right forMajor Depressive Disorder Centre Psychothérapique de Nancy 108
Not applicableStudy completedNCT01488058What this trial is testingCognitive Bias Modification (CBM) and Internet Cognitive Behavioural Therapy (iCBT) for Depression- A Randomised Controlled TrialWho this might be right forDepression Alishia Williams 69
Not applicableStudy completedNCT06372210What this trial is testingA Trial to Assess a Wearable Patch's Functioning to Detect Medication IngestionWho this might be right forMental DisorderSchizophreniaMajor Depressive Disorder+1 more Otsuka Pharmaceutical Development & Commercialization, Inc. 54
Large-scale testing (Phase 3)Study completedNCT04855760What this trial is testingSafety of REL-1017 for Major Depressive DisorderWho this might be right forMajor Depressive Disorder Relmada Therapeutics, Inc. 627
Large-scale testing (Phase 3)Study completedNCT00694304What this trial is testingOpen-label Safety Extension Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in AdultsWho this might be right forMajor Depressive Disorder H. Lundbeck A/S 535
Large-scale testing (Phase 3)Ended earlyNCT03610048What this trial is testingA Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)Who this might be right forRefractory Major Depressive Disorder Alkermes, Inc. 175
Not applicableUnknownNCT05816018What this trial is testingImproving Health Care in Major Depressive DisorderWho this might be right forMajor Depressive Disorder Ospedale San Raffaele 30,900
Testing effectiveness (Phase 2)Looking for participantsNCT07003997What this trial is testingJAK Signaling in DepressionWho this might be right forMajor Depressive Disorder Emory University 100